查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032446

乾癬性關節炎治療市場報告：按藥物類型、疾病類型、給藥途徑、分銷管道和地區分類（2026-2034 年）

Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type, Route of Administration, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球乾癬性關節炎治療市場規模達115億美元。展望未來，IMARC Group預測，到2034年，市場規模將達到241億美元，2026年至2034年的複合年成長率為8.36%。

乾癬性關節炎是一種自體免疫疾病，患者的免疫系統會攻擊關節，導致發炎。治療方法包括口服藥物以減輕腫脹和炎症，以及使用針對特定免疫系統的生物製藥。治療方案會根據疼痛、腫脹和僵硬的程度進行個人化。目前，一些領先的公司正在推出新的治療方法，以幫助阻止疾病進展、減輕疼痛、保護關節並維持關節活動範圍。這些方法可以與物理治療相結合，以增強肌肉和關節力量，並提高整體穩定性。

乾癬性關節炎治療市場趨勢：

銀屑病是乾癬性關節炎的主要風險因素之一。因此，感染疾病、壓力、肥胖、皮膚損傷、酗酒和維生素缺乏等因素導致的銀屑病患病率不斷上升，是推動市場成長的主要因素之一。此外，由於乾癬性關節炎最常發生於30至50歲的人群，全球成年人口的成長也促進了市場成長。另一方面，患有乾癬性關節炎的兒童患葡萄膜炎的風險更高，葡萄膜炎會影響眼球壁的中階。這一事實，加上家長對兒童健康日益成長的關注，正在推動全球對乾癬性關節炎治療的需求。此外，人們對早期診斷和治療乾癬性關節炎益處（例如預防嚴重殘疾）的認知不斷提高，也促進了市場成長。個人可支配收入增加、醫療保健設施改善以及個人健康意識提高等其他因素預計也將推動對治療乾癬性關節炎嚴重症狀的新療法的需求。

本報告解答的主要問題

  • 迄今為止，全球乾癬性關節炎治療市場的發展趨勢是什麼？您預計未來幾年該市場將如何發展？
  • 新冠疫情對全球乾癬性關節炎治療市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 依藥品類型分類，市場組成是怎樣的？
  • 按類型分類的市場組成是什麼？
  • 依行政途徑分類的市場區隔如何？
  • 按分銷管道分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球乾癬性關節炎治療市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球乾癬性關節炎治療市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依藥物類型分類

  • 非類固醇消炎劑（NSAIDs）
  • DMARDs（緩解疾病抗風濕藥物）
  • 生物製劑
  • 其他

第7章 市場區隔：依類型

  • 處方箋
  • OTC

第8章 市場區隔：依給藥途徑

  • 注射藥物
  • 口服
  • 外用

第9章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • AbbVie Inc.
    • Amgen Inc.
    • Amneal Pharmaceuticals LLC
    • AstraZeneca plc
    • Bristol-Myers Squibb Company
    • Eisai Co. Ltd.
    • Eli Lilly and Company
    • Johnson & Johnson Service ltd.
    • Novartis AG
    • Pfizer Inc.
    • Samsung Biologics
    • UCB SA
Product Code: SR112026A4541

The global psoriatic arthritis treatment market size reached USD 11.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 24.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.36% during 2026-2034.

Psoriatic arthritis is an autoimmune disorder wherein the immune system attacks the joints and causes inflammation. Its treatment options vary from oral medications that reduce swelling and inflammation to biological therapies that target the specific immune system. It is treated as per the level of pain, swelling, and stiffness. At present, key players are introducing new treatment methods that help prevent disease progression, reduce pain, protect joints, and preserve the range of motion. These methods can be combined with physical therapy to strengthen muscles and joints and increase overall stability.

PSORIATIC ARTHRITIS TREATMENT MARKET TRENDS:

Psoriasis disease is one of the major risk factors for psoriatic arthritis. As a result, the increasing prevalence of psoriasis disease due to infection, stress, obesity, skin injuries, alcohol abuse, and vitamin deficiencies represents one of the primary factors influencing the market positively. Moreover, as psoriatic arthritis occurs most commonly among individuals between the ages of 30 and 50, the rising adult population worldwide is contributing to the market growth. Apart from this, children with psoriatic arthritis are more likely to develop uveitis that affects the middle layer of tissue in the eyewall. This, in confluence with the growing concerns among parents about the health of their children, is catalyzing the demand for psoriatic arthritis treatment across the globe. In addition, the rising awareness about the benefits of early diagnosis and treatment of psoriatic arthritis, such as preventing serious damages, is bolstering the market growth. Other factors, such as inflating disposable income of individuals, improvement in healthcare facilities, and the growing health awareness among individuals, are anticipated to drive the demand for novel psoriatic arthritis treatment to combat severe symptoms.

KEY MARKET SEGMENTATION:

Breakup by Drug Type:

  • NSAIDs (Nonsteroidal Anti-Inflammatory drugs)
  • DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
  • Biologics
  • Others

Breakup by Type:

  • Prescription
  • OTC

Breakup by Route of Administration :

  • Injectable
  • Oral
  • Topical

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., Amneal Pharmaceuticals LLC, AstraZeneca plc, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Johnson & Johnson Service ltd., Novartis AG, Pfizer Inc., Samsung Biologics and UCB S.A.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global psoriatic arthritis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global psoriatic arthritis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global psoriatic arthritis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Psoriatic Arthritis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Type

  • 6.1 NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 DMARDs (Disease-Modifying Anti-Rheumatic Drugs)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biologics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Prescription
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 OTC
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Injectable
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AbbVie Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Amgen Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amneal Pharmaceuticals LLC
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 AstraZeneca plc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Bristol-Myers Squibb Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eisai Co. Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Eli Lilly and Company
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Johnson & Johnson Service ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Samsung Biologics
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 UCB S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Psoriatic Arthritis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Psoriatic Arthritis Treatment Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Psoriatic Arthritis Treatment Market: Breakup by Drug Type (in %), 2025
  • Figure 5: Global: Psoriatic Arthritis Treatment Market: Breakup by Type (in %), 2025
  • Figure 6: Global: Psoriatic Arthritis Treatment Market: Breakup by Route of Administration (in %), 2025
  • Figure 7: Global: Psoriatic Arthritis Treatment Market: Breakup by Distribution Channel (in %), 2025
  • Figure 8: Global: Psoriatic Arthritis Treatment Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Psoriatic Arthritis Treatment (NSAIDs-Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Psoriatic Arthritis Treatment (DMARDs-Disease-Modifying Anti-Rheumatic Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Psoriatic Arthritis Treatment (Biologics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Psoriatic Arthritis Treatment (Biologics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Psoriatic Arthritis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Psoriatic Arthritis Treatment (Prescription) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Psoriatic Arthritis Treatment (Prescription) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Psoriatic Arthritis Treatment (OTC) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Psoriatic Arthritis Treatment (OTC) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Psoriatic Arthritis Treatment (Injectable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Psoriatic Arthritis Treatment (Injectable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Psoriatic Arthritis Treatment (Oral) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Psoriatic Arthritis Treatment (Oral) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Psoriatic Arthritis Treatment (Topical) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Psoriatic Arthritis Treatment (Topical) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Psoriatic Arthritis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Psoriatic Arthritis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Psoriatic Arthritis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: North America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: North America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: United States: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: United States: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Canada: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Canada: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia-Pacific: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia-Pacific: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: China: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: China: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Japan: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Japan: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: India: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: India: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: South Korea: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: South Korea: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Australia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Australia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Indonesia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Indonesia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Europe: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Europe: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Germany: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Germany: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: France: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: France: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: United Kingdom: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: United Kingdom: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Italy: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Italy: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Spain: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Spain: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Russia: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Russia: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Latin America: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Latin America: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Brazil: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Brazil: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Mexico: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Mexico: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Others: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Others: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Middle East and Africa: Psoriatic Arthritis Treatment Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Middle East and Africa: Psoriatic Arthritis Treatment Market: Breakup by Country (in %), 2025
  • Figure 81: Middle East and Africa: Psoriatic Arthritis Treatment Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Global: Psoriatic Arthritis Treatment Industry: SWOT Analysis
  • Figure 83: Global: Psoriatic Arthritis Treatment Industry: Value Chain Analysis
  • Figure 84: Global: Psoriatic Arthritis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Type (in Million USD), 2026-2034
  • Table 3: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 4: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2026-2034
  • Table 5: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 6: Global: Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Psoriatic Arthritis Treatment Market: Competitive Structure
  • Table 8: Global: Psoriatic Arthritis Treatment Market: Key Players